The addition of plasma CTSD to AST/ALT ratio (AUC = 0.858; p <0.0001) and LSM (AUC = 0.857; p = 0.0258) significantly increased the diagnostic accuracy of both hepatic disease parameters (Fig. 6 and Table S6). This evidence concerns the gene CTSD and liver disorder.